Protocol Hepatitis Medication Therapy Adherence Clinic (Hepatitis MTAC)

With the huge evolvement of Hepatitis C treatment from conventional standard regime which comprises of interferon and ribavirin to the advent of oral Direct Acting Antiviral Agents (DAAs), which promises higher curing rate and shorter treatment duration, more patients will benefit from this treatment.

Therefore, the first edition of the Protocol Hepatitis Medication Therapy Adherence Clinic Hepatitis (Hepatitis MTAC) published in 2015 has been revised. Due to the DAAs’ adverse effect profiles, high potential of drug-drug interactions and potential for non adherence, pharmacists have great opportunity to expand their roles in providing the best pharmaceutical care to the patients.

Document categories: 
Publications
Download files: